Simultaneous Integrated Boost Intensity-Modulated Radiotherapy (SIB-IMRT) Combined with Nimotuzumab for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Phase II Clinical Trial.
BMC Cancer（2024）
关键词
Esophageal squamous cell cancer,SIB-IMRT,Nimotuzumab,Safety,Efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要